These studies illustrate Cagrilintides potential for multi-receptor weight-loss mechanisms and form the basis for translational research
This study established CagriSema as the most effective pharmacotherapy for obesity reported in any Phase 3 trial
(2019) The effects of choline and magnesium co-supplementation on metabolic parameters, inflammation, and endothelial dysfunction in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
IL-33 suppresses GSK-3beta activation through an ST2-independent MyD88/TRAF6/RIP/PI3K/Akt pathway
Bring health, youth and longevity with this powerful co-enzyme
Real-time metabolic flux analysis revealed that MOTS-c treatment significantly increased lipid utilization capacity through increasing OCR, but not ECAR, in the presence of palmitate in C2C12 cells (Fig